Kashmira Gander

By Kashmira Gander

Reporter

0

Share

Newsweek is a Trust Project member

See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.


People with COVID-19, the disease caused by the new coronavirus, have been found to carry antibodies against the bug for at least two weeks after recovering in a small study.

The study could help answer questions about how long a person recovering from coronavirus has antibodies to fight off repeat infections. At the moment, it is not known how long antibodies last or whether a person can get reinfected.

More research is needed to explore what this means for COVID-19 patients' ability to fight off the virus in the future, the researchers said in their paper published in the journal Immunity.

Read More

Antibody That Blocks Coronavirus From Infecting Cells Discovered by Scientists5 min read

Antibody That Blocks Coronavirus From Infecting Cells Discovered by Scientists

Some COVID-19 Patients May Get Seriously Ill Because of the Timing of Their Immune Response, Study Suggests7 min read

Some COVID-19 Patients May Get Seriously Ill Because of the Timing of Their Immune Response, Study Suggests

The Airlines Requiring Passengers to Wear In-Flight COVID-19 Face Masks, Including Delta and American Airlines7 min read

The Airlines Requiring Passengers to Wear In-Flight COVID-19 Face Masks, Including Delta and American Airlines

According to Johns Hopkins University, more than 3.5 million people worldwide have been diagnosed with COVID-19. The U.S. is the country with the most known cases, as shown in the graph by Statista below. As experts told Newsweek last week, it is not yet known whether those who catch the coronavirus are immune in the long term, and this poses obstacles for scientists trying to create vaccines.

covid19, coronavirus, statista,

...

In the latest study, scientists led by Ling Ni from Tsinghua University, Beijing, collected the blood of 14 COVID-19 patients who were discharged from hospital after testing negative for SARS-CoV-2, the scientific name of the coronavirus that causes COVID-19. Eight of the patients were newly discharged and the remaining six left hospital two weeks prior to having their blood collected.

To see if COVID-19 patients have signs of immune response not found in those who had not had the disease, the researchers also used control groups. They assessed blood samples of three healthy people who donated before the COVID-19 pandemic is thought to have started, and three who had been in close contact with the sick patients from the study. They also used blood serum from healthy male donors in the U.S..

The researchers looked at two types of immunity, one involving the creation of antibodies and one centred around specific cells that combat invaders. Signs of both types were detected in the newly discharged patients, suggesting the body uses both arms of the immune system to fight off SARS-CoV-2.

Both the newly discharged patients and those who had been out of hospital for two weeks had antibodies specific to SARS-CoV-2, but not the controls.

The antibodies included those that block the spike protein the virus uses to invade our cells. As such, the team think a vaccine targeting this is worthy of investigation.

Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine in Houston and co-director of the Texas Children's Hospital Center for Vaccine Development, and colleagues are exploring such a vaccine.

The team said that COVID-19 patients appear to maintain levels of one type of antibody at least two weeks after being clear of SARS-CoV-2. In addition, the scientists took antibodies from the patients, and found 13 of them neutralized a mocked up version of the SARS-CoV-2 virus in a lab.

"These findings suggest that most patients post discharge have serum neutralizing SARS-CoV-2 infection," they said.

The work echoes the findings of a separate study showing that blood serum of patients appears to block SARS-CoV-2 from invading cells, according to the researchers.

But they acknowledged their work needs to be confirmed in a larger group of COVID-19 patients. However, they believe the paper provides a launchpad for investigating whether those who catch SARS-CoV-2 become immune in the long term, and has implications for developing a vaccine.

Centers for Disease Control and Prevention Advice on Using Face Coverings to Slow Spread of COVID-19

World Health Organization advice for avoiding spread of coronavirus disease (COVID-19)

Hygiene advice

Medical advice

Mask and glove usage

View 0 Comments

Request Reprint & Licensing

Submit Correction

View Editorial & AI Guidelines